BioSpace News Archive

Health Vector, a Boston based health and wellness company, announced today the release of its first app

Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), announced plans to award Dr. Kanneboyina Nagaraju and his team at Binghamton University’s School of Pharmacy and Pharmaceutical Sciences a $329,000 grant.

Medica today announced grants totaling $70,000 to two Omaha, Neb., health care organizations.

Golub Capital recently announced that, as Administrative Agent, Sole Lead Arranger and Sole Bookrunner, it provided a GOLD facility to support the acquisition of CRH Healthcare (“CRH” or “the Company”) by Freeman Spogli & Co. (“Freeman Spogli”), in partnership with CRH management.

Novacap, a global player in the pharmaceutical synthesis and specialty ingredients, with a broad portfolio of products and services and a wide range of technologies, today announced that it will combine its Contract Development and Manufacturing Organization subsidiaries – PCI Synthesis, PCAS, Uetikon and Proteus – into a new entity to be known as SEQENS.

Working with a $4 million grant from the USDA National Institute of Food and Agriculture, Auburn University researchers are addressing the gaps between knowledge and practice in the production and distribution of local and regional foods, with the ultimate goal of ensuring a more secure food chain.

Kali, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced the new Kali Cannabis Therapies subsidiary to develop cannabis biotechnology treatment alternatives to chemical pharmaceuticals.

Voluntis (Paris:VTX) (Euronext Paris, Mnemo: VTX - ISIN: FR0004183960), a company specialized in digital therapeutics, announces today that it has entered into a collaboration with AbbVie, a research-based global biopharmaceutical company, to enhance patient care coordination in immunology with innovative digital therapeutic software.

NuggMD, the nation’s leading telemedicine platform that connects prospective medical cannabis patients with licensed doctors online, announced today that it will expand services to Nevada.

TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) (“TerrAscend”) is pleased to announce that it has finalized the previously announced US$75 million credit facility with certain funds managed by JW Asset Management LLC, where Jason Wild, Chairman of the Board of TerrAscend, is the President and Chief Investment Officer.